The positive trends of the biotech industry witnessed during the pandemic years have been gradually ebbing away. Considering this, investors could avoid weak biotech stocks Day One Biopharmaceuticals, Inc. (DAWN), Northwest Biotherapeutics, Inc. (NWBO), and Ocugen, Inc. (OCGN) for the reasons mentioned in the article.
The biotech industry has diversified and thrived over the past couple of decades, especially during the pandemic, owing to the persistent demand and advanced innovations. However, given the headwinds it faces, the industry is anticipated to remain under some pressure.
